Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Amicus Therapeutics
Work at Amicus Therapeutics?
Add yourself to this profile
533
Amicus Therapeutics
Biotech
Edit Profile
amicusrx.com
Health Care
Technology
>
Biotechnology
B2b
Founded in
2002
Raised
$41M
More info
Elsewhere
Companies in the same industry
Flexion Therapeutics
doublehelix design
Caterna
Centre for Sight
Crucell
Sway Medical
BluPanda
Jivana Biotechnology
Apama Medical
Fibrocell Science
Alexa global traffic share
Twitter followers
Overview
Funding
2
Acquisitions
2
Add info
Latest funding
Debt financing
$10,000,000
Venture capital (Series B)
$31,000,000
Employees
Team size
50+
Locations
Unknown
Help us complete this profile
Xconomy
Amicus Takes Aim at Rare Brain Disorder with MiaMed Acquisition
Health
Xconomy
Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug
Health
The Motley Fool
Why Amicus Therapeutics, Inc. Stock Slumped 14.0% in April
The Motley Fool
What Caused Amicus Therapeutics Shares To Skyrocket 23% Last Month
Health
Stock markets
The Motley Fool
Amicus Therapeutics Closes In on a 9-Figure Opportunity
The Motley Fool
3 Emerging Biotech Stocks I'm Watching Like a Hawk
The Motley Fool
Why Amicus Therapeutics Shares Are Skyrocketing Again Today
Stock markets
The Motley Fool
Why Amicus Therapeutics Shares Are Up Today
Stock markets
The Motley Fool
Why Amicus Therapeutics Shares Are Soaring 10% Today --
Stock markets
Health
Flexion Therapeutics
doublehelix design
Caterna
Centre for Sight
Crucell
Sway Medical